FDA Inspection
Randy J. Epstein, M.D.Randy J. Epstein, M.D. – FDA Inspection, Oct 26, 2022
Record Details
This FDA Inspection record concerns Randy J. Epstein, M.D., with an inspection on October 26, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Randy J. Epstein, M.D.
- Inspection Date
- October 26, 2022
- Product Type
- Drugs
View Company Profile
ID · d7f83748-4418-4521-8428-b25d4c26be4d
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1182088
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
4- 21 CFR 50.27(a)Consent form not approved/signed/dated
- 21 CFR 312.62(a)Accountability records
- 21 CFR 312.57(a)Records of receipt, shipment, disposition
- 21 CFR 312.20(a)Failure to submit an IND
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.